Cost‐Effectiveness of Drug‐Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET‐SMALL 2 Randomized Controlled Trial

Cost‐Effectiveness of Drug‐Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET‐SMALL 2 Randomized Controlled Trial

Background Drug‐coated balloons (DCB) are noninferior to second‐generation drug‐eluting stents (DES) in the treatment of small vessel coronary artery disease regarding major adverse cardiac events (MACE). However, the economic implication of this finding is unclear. Methods In the BASKET‐SMALL 2 stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco E. G. V. Cattaneo, Michael Coslovsky, Samuel J. P. Malkin, Gregor Fahrni, Christoph Kaiser, Nicole Gilgen, Bruno Scheller, Raban V. Jeger
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cost‐effectiveness analysis
drug‐coated balloons
major adverse cardiac events
percutaneous coronary intervention
quality‐adjusted life expectancy
second‐generation drug‐eluting stents
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.037214
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.037214

Similar Items